SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 128 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2015. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $143,000 | -35.0% | 49,421 | 0.0% | 0.12% | -7.8% |
| Q2 2017 | $220,000 | -4.3% | 49,421 | 0.0% | 0.13% | +8.5% |
| Q1 2017 | $230,000 | -46.5% | 49,421 | -29.9% | 0.12% | -3.3% |
| Q4 2016 | $430,000 | -42.2% | 70,530 | -47.8% | 0.12% | -21.3% |
| Q3 2016 | $744,000 | +45.0% | 135,065 | 0.0% | 0.16% | +21.1% |
| Q2 2016 | $513,000 | +60.8% | 135,065 | +16.8% | 0.13% | +29.3% |
| Q1 2016 | $319,000 | -46.8% | 115,670 | +2.1% | 0.10% | -38.1% |
| Q3 2015 | $600,000 | -36.2% | 113,276 | 0.0% | 0.16% | -9.6% |
| Q2 2015 | $940,000 | +79.7% | 113,276 | 0.0% | 0.18% | +90.3% |
| Q1 2015 | $523,000 | +147.9% | 113,276 | +63.9% | 0.09% | +173.5% |
| Q4 2014 | $211,000 | – | 69,110 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 477,621 | $1,065,000 | 1.44% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,505,804 | $3,358,000 | 1.18% |
| Nantahala Capital Management | 7,000,000 | $15,610,000 | 0.69% |
| Hikari Power Ltd | 1,900,000 | $4,237,000 | 0.50% |
| Trellus Management Company, LLC | 112,500 | $251,000 | 0.34% |
| Cheyne Capital Management (UK) LLP | 206,500 | $462,000 | 0.20% |
| KNOTT DAVID M | 201,400 | $449,000 | 0.18% |
| Paulson & Co. | 4,000,000 | $8,920,000 | 0.17% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,041,695 | $2,323,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 318,460 | $710,000 | 0.13% |